Shanghai Model Organisms Center(SH:688265) Shang Hai Zheng Quan Bao·2025-06-27 21:30Group 1 - The core point of the news is the equity change report regarding Shanghai Southern Model Biotechnology Co., Ltd, where Suzhou Haiwang Hezong No. 1 Equity Investment Partnership (Limited Partnership) is increasing its shareholding in the company [1][2] - The report indicates that the equity change is based on the confidence in the company's future development and long-term investment value recognition [9] - The report outlines that the equity change requires compliance confirmation from the Shanghai Stock Exchange and registration procedures with the China Securities Depository and Clearing Corporation [5][38] Group 2 - The information disclosing party, Suzhou Haiwang Hezong, has not held shares in the company prior to this equity change, while its action partner, Shanghai Pudong New Industry Investment Co., Ltd., held 2,160,000 shares, accounting for 2.77% of the total share capital [12][13] - After the equity change, the information disclosing party will hold 8,679,727 shares, representing 11.13% of the total share capital, while the combined holdings with its action partner will total 10,839,727 shares, or 13.90% of the total share capital [12][13] - The share transfer agreement specifies that the shares will be transferred at a price of 27.369 yuan per share, with the total transfer price amounting to approximately 127.27 million yuan [15][56] Group 3 - The report confirms that the equity change does not trigger a mandatory tender offer and will not lead to changes in the controlling shareholder or actual controller of the company [39] - The report also states that the equity change complies with relevant laws and regulations, including the Securities Law and the Acquisition Measures [39] - The information disclosing party has committed to not reduce its holdings in the company for 12 months following the completion of the share transfer [11]